Search

Author/Creator Csaba Nagy A. investigator.

1. Sacubitril/valsartan eligibility and outcomes in the ESC‐EORP‐HFA Heart Failure Long‐Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM‐HF trial, ESC guidelines, and real world. (18th June 2019)

Authors:
Kapelios, Chris J.; Lainscak, Mitja; Savarese, Gianluigi; Laroche, Cécile; Seferovic, Petar; Ruschitzka, Frank; Coats, Andrew; Anker, Stefan D.; Crespo‐Leiro, Maria G.; Filippatos, Gerasimos; Piepoli, Massimo F.; Rosano, Giuseppe; Zanolla, Luisa; Aguiar, Carlos; Murin, Jan; Leszek, Przemyslaw; Mc...
Other Names:
Auer J. investigator.; Ablasser K. investigator.; Fruhwald F. investigator.; Dolze T. investigator.; Brandner K. investigator.; Gstrein S. investigator.; Poelzl G. investigator.; Moertl D. investigator.; Reiter S. investigator.; Podczeck‐Schweighofer A. investigator.; Muslibegovic A. investigator...
Journal:
European journal of heart failure
Issue:
Volume 21:Number 11(2019)
Page Start:
1383
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search